Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry

被引：0
|
作者：
Garcia Vega, D. [1 ]
Cinza-Sanjurjo, S. [2 ]
Eiras, S. [3 ,4 ]
Gonzalez-Juanatey, J. R. [1 ]
机构：
[1] Univ Hosp Santiago de Compostela, Santiago De Compostela, Spain
[2] Ctr Salud Milladoiro, Area Sanitaria Santiago de Compostela, Santiago De Compostela, Spain
[3] Hlth Res Inst Santiago de Compostela, Santiago De Compostela, Spain
[4] CIBERCV, Santiago De Compostela, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：591 / 591
页数：1
相关论文
共 50 条
  • [11] GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?
    Du, Lixin
    Zhang, Yu
    Wang, Pan
    Li, Zhigang
    Zhao, Yunhui
    Yuan, Jianpeng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 366 : 31 - 31
  • [12] One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA
    Zhang, Mengqing
    Lin, Chu
    Cai, Xiaoling
    Jiao, Ruoyang
    Bai, Shuzhen
    Li, Zonglin
    Lv, Fang
    Yang, Wenjia
    Liu, Geling
    Yang, Xiaolin
    Ji, Linong
    DIABETES OBESITY & METABOLISM, 2024,
  • [13] Reply to "GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?"
    Hwang, In-Chang
    Kim, Chee Hae
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 369 : 12 - 12
  • [14] Predictors of Selection of a GLP1RA vs. SGLT2i in People with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
    Agarwal, Shubham
    Basit, Mujeeb A.
    Bowen, Michael E.
    Heitjan, Daniel
    Mai, Christine
    Marble, Kelsea
    Xiang, Zichang
    Lingvay, Ildiko
    DIABETES, 2024, 73
  • [15] Different Effect on UACR According to Predetermined Treatment Schedule Groups (GLP1RA or SGLT2i) Therapy in T2DM
    Carretero Gomez, Juana
    Ena, Javier
    Miguel Segui-Ripoll, Jose
    Javier Carrasco-Sanchez, Francisco
    Arevalo Lorido, Jose Carlos
    Suarez Tembra, Manuel
    Manuel Varela, Jose
    Gomez-Huelgas, Ricardo
    DIABETES, 2020, 69
  • [16] GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
    Pablo, Aschner
    Evelyn, Blanc
    Claudia, Folino
    Yanina, Morosan A.
    CURRENT HYPERTENSION REVIEWS, 2021, 17 (02) : 149 - 158
  • [17] Extraglycemic Effects of SGLT2i/GLP1-ra: A Topic Update
    Alam, Uazman
    CLINICAL THERAPEUTICS, 2024, 46 (11) : 826 - 827
  • [18] Association of Initiating SGLT2i and GLP1Ra Therapeutics on Insulin Utilization and MACE Outcomes Among Patients With Diabetes in an Integrated Healthcare System
    Le, Viet T.
    May, Heidi T.
    Bair, Tami L.
    Knight, Stacey
    Horne, Benjamin D.
    Knowlton, Kirk U.
    Anderson, Jeffrey L.
    CIRCULATION, 2023, 148
  • [19] IMPLEMENTING ADHERENCE TO SGLT2I AND GLP1RA IN PATIENTS WITH CARDIOVASCULAR DISEASE: FINDINGS FROM A PHARMACIST-DRIVEN CARDIODIABETES CLINIC PROGRAM
    Lee, Kevin
    Ikram, Mashaal
    Mishkel, Gregory J.
    Ng, Elaine
    Krupa, Edyta
    Zahvolskyy, Lidiya
    Davidson, David Jeremy
    Gordon, Robert Andrew
    Billings, Liana
    Sarav, Menaka
    Block, Romy
    Erwin, John P., III
    Qamar, Arman
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1938 - 1938
  • [20] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Khat, Dorrin Zarrin
    Husain, Mansoor
    CURRENT DIABETES REPORTS, 2018, 18 (07)
12345